San Diego's Histogen, a regenerative medicine company with technology for using nascent skin cells to produce "cosmeceutical" products, says the FDA has given a green light to its application for an initial safety study of its hair stimulation product in women. In the United States, Histogen says hair loss affects over 40 million men and [...]